Kevin D. Brandt
2020 - Xtant Medical Holdings
In 2020, Kevin D. Brandt earned a total compensation of $821.4K as Chief Commercial Officer at Xtant Medical Holdings, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $176,375 |
|---|---|
| Option Awards | $108,469 |
| Salary | $417,554 |
| Stock Awards | $107,557 |
| Other | $11,400 |
| Total | $821,355 |
Brandt received $417.6K in salary, accounting for 51% of the total pay in 2020.
Brandt also received $176.4K in non-equity incentive plan, $108.5K in option awards, $107.6K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Kevin D. Brandt's compensation ranked 9,409th out of 13,090 executives tracked by ExecPay. In other words, Brandt earned more than 28.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,409 out of 13,090 | 28th |
Division Manufacturing | 4,027 out of 5,617 | 28th |
Major group Chemicals And Allied Products | 1,636 out of 2,248 | 27th |
Industry group Drugs | 1,432 out of 1,948 | 27th |
Industry Biological Products, Except Diagnostic Substances | 335 out of 411 | 19th |
Source: SEC filing on June 14, 2021.
Brandt's colleagues
We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2020.
News
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021
Xtant Medical Holdings CEO Carl O'Connell's 2018 pay jumps 224% to $1.8M
September 20, 2019